These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 2421228)
1. Evidence that the reduced surface antigenicity of developing Schistosoma mansoni schistosomula is due to antigen shedding rather than host molecule acquisition. Pearce EJ; Basch PF; Sher A Parasite Immunol; 1986 Jan; 8(1):79-94. PubMed ID: 2421228 [TBL] [Abstract][Full Text] [Related]
2. A major role for carbohydrate epitopes preferentially recognized by chronically infected mice in the determination of Schistosoma mansoni schistosomulum surface antigenicity. Omer-Ali P; Magee AI; Kelly C; Simpson AJ J Immunol; 1986 Dec; 137(11):3601-7. PubMed ID: 2431038 [TBL] [Abstract][Full Text] [Related]
3. Temporal variation in the carbohydrate and peptide surface epitopes in antibody-dependent, eosinophil-mediated killing of Schistosoma mansoni schistosomula. Langley JG; Dunne DW Parasite Immunol; 1992 Mar; 14(2):185-200. PubMed ID: 1373883 [TBL] [Abstract][Full Text] [Related]
4. Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo. Pearce EJ; James SL Parasite Immunol; 1986 Sep; 8(5):513-27. PubMed ID: 3534695 [TBL] [Abstract][Full Text] [Related]
5. Antigenicity and immunogenicity of the tegumental outer membrane of adult Schistosoma mansoni. Payares G; McLaren DJ; Evans WH; Smithers SR Parasite Immunol; 1985 Jan; 7(1):45-61. PubMed ID: 2581216 [TBL] [Abstract][Full Text] [Related]
6. Studies on the surface antigenicity and susceptibility to antibody-dependent killing of developing schistosomula using sera from chronically infected mice and mice vaccinated with irradiated cercariae. Bickle QD; Ford MJ J Immunol; 1982 May; 128(5):2101-6. PubMed ID: 7061855 [TBL] [Abstract][Full Text] [Related]
7. Changes in the surface antigen profile of Schistosoma mansoni during maturation from cercaria to adult worm. Payares G; McLaren DJ; Evans WH; Smithers SR Parasitology; 1985 Aug; 91 ( Pt 1)():83-99. PubMed ID: 4034248 [TBL] [Abstract][Full Text] [Related]
8. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts. James SL; Pearce EJ; Sher A J Immunol; 1985 May; 134(5):3432-8. PubMed ID: 3980998 [TBL] [Abstract][Full Text] [Related]
9. The presence of antibody in mice chronically infected with Schistosoma mansoni which blocks in vitro killing of schistosomula. Yi XY; Simpson AJ; de Rossi R; Smithers SR J Immunol; 1986 Dec; 137(12):3955-8. PubMed ID: 3097137 [TBL] [Abstract][Full Text] [Related]
10. Protective monoclonal antibodies from mice vaccinated or chronically infected with Schistosoma mansoni that recognize the same antigens. Gregoire RJ; Shi MH; Rekosh DM; Loverde PT J Immunol; 1987 Dec; 139(11):3792-801. PubMed ID: 2445819 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens. El-Faham MH; Eissa MM; Igetei JE; Amer EI; Liddell S; El-Azzouni MZ; Doenhoff MJ PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005853. PubMed ID: 28841653 [TBL] [Abstract][Full Text] [Related]
13. The ability of fractionated sera from animals vaccinated with irradiated cercariae of Schistosoma mansoni to transfer immunity to mice. Jwo J; LoVerde PT J Parasitol; 1989 Apr; 75(2):252-60. PubMed ID: 2466975 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in the loss of antibody-mediated adherence of macrophages to lung-stage schistosomula of Schistosoma mansoni in vitro. Lawson BW; Bickle QD; Taylor MG Parasitology; 1993 Jun; 106 ( Pt 5)():463-9. PubMed ID: 8341582 [TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats. Sepulveda J; Tremblay JM; DeGnore JP; Skelly PJ; Shoemaker CB Int J Parasitol; 2010 Oct; 40(12):1407-17. PubMed ID: 20600071 [TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni surface glycoproteins. Analysis of their expression and antigenicity. Payares G; Simpson JG Eur J Biochem; 1985 Nov; 153(1):195-201. PubMed ID: 2415361 [TBL] [Abstract][Full Text] [Related]
17. Schistosoma mansoni: detection by monoclonal antibody of a 22,000-dalton surface membrane antigen which may be blocked by host molecules on lung stage parasites. Harn DA; Mitsuyama M; Huguenel ED; David JR J Immunol; 1985 Sep; 135(3):2115-20. PubMed ID: 4020141 [TBL] [Abstract][Full Text] [Related]
18. Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase is a lung-stage schistosomula surface membrane antigen. Tallima H; El Ridi R Folia Parasitol (Praha); 2008 Sep; 55(3):180-6. PubMed ID: 19202676 [TBL] [Abstract][Full Text] [Related]
19. Antibodies are involved in the protective immunity induced in mice by Schistosoma mansoni schistosomula tegument (Smteg) immunization. Melo TT; Sena IC; Araujo N; Fonseca CT Parasite Immunol; 2014 Feb; 36(2):107-11. PubMed ID: 24558655 [TBL] [Abstract][Full Text] [Related]
20. Expression of lectin-binding surface glycoproteins during the development of Schistosoma mansoni schistosomula. Hayunga EG; Sumner MP J Parasitol; 1986 Dec; 72(6):913-20. PubMed ID: 3819968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]